Ophthalmic Business News

NEW YORK — Richard C. Edlow, OD, discusses the increasing shift toward private equity in the first part of his presentation from OSN New York 2021.

We are all intrigued with successful, driven professionals that set lofty goals and reach them. Self-described "serial entrepreneurs" and partners Jerry St. Peter and Jason Werner were fresh off their success with Sun Ophthalmics when they struck out on their own. Putting together private equity and investors, the pair launched Eyevance Pharmaceuticals in 2017 and by 2019, they had a commercial team in place with territory managers and multiple products on the market. In 2020, Eyevance was acquired by Santen thanks to the great team of people and commercial opportunities that Eyevance developed with unparalleled efficiency.

About 2 years ago, my practice took a deep dive into private equity.

EyePoint Pharmaceuticals has announced the appointment of Jay S. Duker, MD, as chief operating officer, according to a company press release.

Consumers should be aware of Medicare Advantage plans limiting therapy through prior authorization and step therapy requirements during open enrollment, according to a press release from AAO and ASCRS.

As we approach year end, many physicians inquire about ways to reduce their tax obligations for the current tax year.

Cost-effectiveness in ophthalmic surgery was the topic of a symposium at the ESCRS meeting.

Curacle and Théa Open Innovation have entered an agreement for the development of the potential first oral treatment for diabetic macular edema, according to a press release.

In this Healio Video Perspective from the ASRS meeting, Josh Anderson, head of U.S. retina sales and marketing at Alcon, discusses how upcoming innovations can benefit retina surgeons.

In this episode, Jennifer L. Mogan, MD, discusses her path into medicine, the importance of the credit card process and how it can be beneficial for eyecare practices.